ArticleMolecular pharmaceutics2014

Dipeptidyl peptidase IV as a potential target for selective prodrug activation and chemotherapeutic action in cancers.

Arik Dahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.